This timeline aligns with the natural turnover cycle of epidermal cells, suggesting KPV needs time to influence the new cell populations as they differentiate and migrate to the surface
Injury severity, age, metabolic health, protein intake, sleep quality, training load, inflammation, and rehabilitation strategy all matter
That would mean that despite the agency having found reasons for concerns about risks, and limited evidence for any benefit, the FDA would turn a blind eye to the compounding of these peptides and their use by the public moving forward
Category 2 is used for substances the agency believes may present safety risks, which means compounding pharmacies could not legally prepare those compounds for patient use
It is generally administered either into a muscle (intramuscularly) or a vein (intravenously)